Concepedia

Haruyasu Murakami

HM

Statistics

Publications

181

Citations

8.7K

H-Index

49

Active since

2005

Affiliations

Shizuoka Cancer Center(Current)

Wakayama Medical University

National Cancer Center Hospital East

Kindai University

Japanese Foundation For Cancer Research

Haruyasu Murakami is an author at Shizuoka Cancer Center specializing in oncology, medicine, and lung cancer.

ORCID

Publications per year

2005–2025

181

Publications

181

Entrectinib in ROS1 fusion-positive non-small-cell lung cancer: integrated analysis of three phase 1–2 trials

Alexander Drilon, Salvatore Siena, Rafał Dziadziuszko et al. · The Lancet Oncology · 2019 · 537 citations · Full text

, , +15

Vandetanib in patients with previously treated RET-rearranged advanced non-small-cell lung cancer (LURET): an open-label, multicentre phase 2 trial

Kiyotaka Yoh, Takashi Seto, Miyako Satouchi et al. · The Lancet Respiratory Medicine · 2016 · 295 citations

, , +9

The Risk of Cytotoxic Chemotherapy-Related Exacerbation of Interstitial Lung Disease with Lung Cancer

Hirotsugu Kenmotsu, Tateaki Naito, Madoka Kimura et al. · Journal of Thoracic Oncology · 2011 · 228 citations · Full text

, , +16

Lenvatinib in patients with advanced or metastatic thymic carcinoma (REMORA): a multicentre, phase 2 trial

Jun Sato, Miyako Satouchi, Shoichi Itoh et al. · The Lancet Oncology · 2020 · 209 citations

, , +11

Increases of Amphiregulin and Transforming Growth Factor-α in Serum as Predictors of Poor Response to Gefitinib among Patients with Advanced Non–Small Cell Lung Cancers

Nobuhisa Ishikawa, Yataro Daigo, Atsushi Takano et al. · Cancer Research · 2005 · 192 citations

, , +9

1–5 of 181